Radioiodine for thyroid cancer--is less more?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Less is more: once vs. multiple radioactive iodine (RAI) therapy in patients with RAI-avid pulmonary micrometastatic differentiated thyroid cancer.European journal of nuclear medicine and molecular imaging · 2025
   Article
2. Mechanisms of regulating NIS transport to the cell membrane and redifferentiation therapy in thyroid cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
   Review
3. Analysis of NIS Plasma Membrane Interactors Discloses Key Regulation by a SRC/RAC1/PAK1/PIP5K/EZRIN Pathway with Potential Implications for Radioiodine Re-Sensitization Therapy in Thyroid Cancer.Cancers · 2021
   Article
4. Long-Term Oncological Outcome Comparison between Intermediate- and High-Dose Radioactive Iodine Ablation in Patients with Differentiated Thyroid Carcinoma: A Propensity Score Matching Study.International journal of endocrinology · 2021
   Article
5. A rapidly increasing trend of thyroid cancer incidence in selected East Asian countries: Joinpoint regression and age-period-cohort analyses.Gland surgery · 2020
   Article
6. Implications of NaJournal of the Endocrine Society · 2019
   Review
7. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.Journal of cancer epidemiology · 2013
   Article
8. Radioiodine treatment of well-differentiated thyroid cancer.Endocrine · 2012
   Review
9. Radiotherapy: radioiodine in thyroid cancer-how to minimize side effects.Nature reviews. Clinical oncology · 2012
   Article
10. To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients.Journal of oncology · 2012
    Article

Corrections and comments

• Commented on by
  Radioiodine ablation in low-risk thyroid cancer.2012
• Comment on
  Strategies of radioiodine ablation in patients with low-risk thyroid cancer.2012
• Comment on
  Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.2012

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as